Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term 0 (Transcription Factors). Found 4 abstracts

Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD, Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Developmental cell. 2005 Jan;8(1):19-30.
Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Gynecologic Oncology. 2004 Dec;95(3):449-55.
Hardy RR. B-cell commitment: deciding on the players. Current Opinion in Immunology. 2003 Apr;15(2):158-65.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term 0 (Transcription Factors)

Transcription Factors 0 (Transcription Factors) ph [Physiology] me [Metabolism] bi [Biosynthesis] Cell Cycle 0 (Cell Cycle Proteins) Cell Cycle Proteins Non-US Gov't Research Support Female Dosage Compensation (Genetics) Cell Line 0 (macroH2A histone) 0 (Wnt proteins) Mice cy [Cytology] protein HP-1) Cell Aging Carcinogens Immunohistochemistry 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine) Experimental Mammary Neoplasms 0 (Sulfonamides) 41598-07-6 (Prostaglandin D2) Cytoplasmic and Nuclear Receptors 0 (Fluorenes) Zebrafish Proteins ai [Antagonists & Inhibitors] Messenger) 0 (RNA Methylnitrosourea Dinoprostone Indoles 0 (15-deoxyprostaglandin J2) Loss of Heterozygosity en [Enzymology] Messenger RNA Biological Models Time Factors 0 (Anticarcinogenic Agents) Histones ras Proteins Sprague-Dawley Rats 0 (Neoplasm Proteins) Cell Count Neoplasm Proteins Non-Histone Chromosomal Proteins 169590-42-5 (celecoxib) Single Nucleotide Polymorphism human) 0 (PLAGL1 protein 0 (Proto-Oncogene Proteins) Membrane Proteins Repressor Proteins Gene Expression Regulation human) 0 (ASF1A protein 363-24-6 (Dinoprostone) 0 (notch protein) 0 (Cyclooxygenase Inhibitors) Western Blotting Gene Expression du [Diagnostic Use] 0 (Zebrafish Proteins) Amino Acid Sequence Isoenzymes Drug Synergism Prostaglandin D2 EC 3-6-1 (ras Proteins) 0 (Recombinant Fusion Proteins) 0 (Indoles) Immunoprecipitation 0 (Isoenzymes) Comparative Study Cell Division ge [Genetics] ci [Chemically Induced] Sulfonamides Heterochromatin Human Chromosomes-Pair 6 107283-02-3 (heterochromatin-specific nonhistone chromosomal ad [Administration & Dosage] 0 (Histones) EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) Apoptosis Ovarian Neoplasms pd [Pharmacology] 61-90-5 (Leucine) de [Drug Effects] Prostaglandin-Endoperoxide Synthase human) 143220-95-5 (PML protein pc [Prevention & Control] mt [Methods] Tumor Suppressor Genes Alleles 0 (Heterochromatin) Proto-Oncogene Proteins Transfection Non-Histone) 0 (Chromosomal Proteins 0 (Membrane Proteins) Anticarcinogenic Agents Nuclear Proteins Cytoplasmic and Nuclear) 0 (Receptors 0 (Carcinogens) 0 (Nuclear Proteins) 0 (Repressor Proteins) ag [Agonists] zebrafish) 0 (wnt8b protein Fluorenes 684-93-5 (Methylnitrosourea) Cell Lineage Rats B-Lymphocytes Recombinant Fusion Proteins aa [Analogs & Derivatives] 47165-04-8 (dapi) Cyclooxygenase Inhibitors Breast Neoplasms EC 1-14-99-1 (cyclooxygenase 2) Leucine
Last updated on Wednesday, February 05, 2020